+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06535854

Evaluating the Prevail Drug-Coated Balloon for Treating In-stent Restenosis and Small Vessel Disease in Coronary Artery Disease

Led by Medtronic Vascular · Updated on 2026-10-21

1205

Participants Needed

79

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the Prevail Drug-Coated Balloon DCB in people with coronary artery disease undergoing percutaneous coronary intervention PCI. The study includes two groups one with in-stent restenosis ISR randomized to receive either the Prevail DCB or the Agent DCB, and another with de novo lesions in small vessel disease DNSV treated with the Prevail DCB and compared to historical data from drug-eluting stents. The study aims to assess the clinical safety and effectiveness of the Prevail DCB in these conditions. Participants in the ISR group will be randomly assigned to receive either the Prevail DCB or the Agent DCB during PCI to treat lesions in coronary arteries previously treated with drug-eluting or bare metal stents. The DNSV group will receive the Prevail DCB for new lesions in small vessels. Both devices are paclitaxel-coated balloons designed for vessels 2.00 mm to 4.00 mm in diameter. Enrollment will take place at about 85 global sites over approximately 12 months. Participants will be followed with clinical assessments for up to 5 years or until study exit or death. Researchers will monitor outcomes such as restenosis, cardiac events including myocardial infarction and death, and the need for repeat procedures at various timepoints from hospital discharge through 5 years. Safety and efficacy will be tracked through visits and evaluations at 30 days, 6, 12, 24, 36, 48, and 60 months after the procedure to gather long-term data on the devices.

CONDITIONS

Brief Title

Prevail Global Study

Research Team

J

Jeroen Frijhoff

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here